Search - tctmd.com

Presenter: Koen Teeuwen, Ben Van den Branden, Jacques Koolen, Jose Henriques, Jan Tijssen, Hans Kelder, Ren? Van der Schaaf, Paul Vermeersch, Benno Rensing, Maarten j. Suttorp

January 31, 2013

Presentation TCT 2013

THREE YEAR FOLLOW UP OF A RANDOMIZED COMPARISON OF NOBORI, BIOLIMUS A9 ELUTING STENT(BES) WITH CYPHER, SIROLIMUS ELUTING STENT(SES) FOR CORONARY REVASCULARIZATION IN JAPANESE...

Presenter: Takeshi Kimura, Toshiya Muramatsu, Masashi Iwabuchi, Shigeru Saito, Yasuhiko Hayashi, Yuji Ikari, Kenshi Fujii, Shinsuke Nanto, Naoto Inoue, Atsuo Namiki, Haruo Hirayama, Osamu Doi, Mitsuo Kashida, Junji Yajima, Kazuaki Mitsudo

January 31, 2013

Advertisement

STENTYS to Present First Results of Sirolimus-Eluting Self-Apposing® Stent at TCT Conference

Triple Antiplatelet Therapy May be Better for Longer Stent Lengths

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich’s COMBO Dual Therapy Stent™ in Routine Practice

SES Show Advantage Over ZES, PES for Diabetic Patients

Micell Technologies Receives CE Mark Approval for MiStent SES

Meta-analysis: Cobalt-Chromium EES Take the Lead Over BMS, Other DES in STEMI

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

First-in-man study of dedicated bifurcation sirolimus-eluting stent BiOSS LIM® – complete 6-month clinical results

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Nordic Bifurcation Study at 5 Years: Stick to Simple Stenting Strategy

REMEDEE Published: ‘Dual Therapy’ Stent Passes Early Efficacy, Safety Tests

The REMEDEE Trial: A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent with a PES

Los SLE No son Inferiores a los SLS en el Tratamiento de las Oclusiones Coronarias Totales

EES Noninferior to SES for Treating Total Coronary Occlusions

Randomized Comparison of Sirolimus-eluting (SES) and Everolimus-eluting (EES) Coronary Stents in the Treatment of Total Coronary Occlusions

Two-year Clinical Outcomes Of Primary Stenting Of Totally Occluded Native Coronary Arteries III (PRISON III): A Randomized Comparison Of Sirolimus-Eluting Stent Implantation Wit...

THREE YEAR FOLLOW UP OF A RANDOMIZED COMPARISON OF NOBORI, BIOLIMUS A9 ELUTING STENT(BES) WITH CYPHER, SIROLIMUS ELUTING STENT(SES) FOR CORONARY REVASCULARIZATION IN JAPANESE...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content